Han Xu

471 citations
20 papers · 340 indexed · h-index 8

Han Xu

18 papers receiving 336 citations

Peers

Han Xu
Comparison fields: 5 of 76
  • Obstetrics and Gynecology 72
  • Pharmacology 36
  • Immunology and Allergy 23
  • Cancer Research 46
  • Toxicology 10
Replace Hiroaki Shimada with:
Hiroaki Shimada Japan
Yusuf Ziya İğci Türkiye
Horng-Mo Lee Taiwan
Youngsic Jeon South Korea
Dean P. Jones United States
Pham Ngoc Khoi South Korea
Peter W. Lindinger Switzerland
Juliane Riha Austria
Antonio Celardo Italy
Carol A. Perry United States
Han Xu relative to Hiroaki Shimada Japan Hiroaki Shimada's profile →
Citations per field
00.5×
Hiroaki Shimada · 1×
Citations per year

Countries citing papers authored by Han Xu

Since Specialization
Citations

This map shows the geographic impact of Han Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Han Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Han Xu more than expected).

Fields of papers citing papers by Han Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Han Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Han Xu. The network helps show where Han Xu may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Han Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Han Xu Line = papers co-authored together Han Xu links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20240
2 20240
3 20241
4 20231
5 20221
6 20212
7
Advances in Research on Genotyping and the Molecular Mechanism of Pancreatic Neuroendocrine Neoplasias
20201
8 202017
9 20197
10 201830
11 201825
12 201838
13 20153
14 20123
15 20115
16 20111
17 201122
18 200963
19 200993
20 200927

About Han Xu

Han Xu is a scholar working on Obstetrics and Gynecology, Pharmacology and Molecular Biology, having authored 20 papers that have together received 340 indexed citations. Recurring topics across this work include Ginseng Biological Effects and Applications (5 papers), Metabolomics and Mass Spectrometry Studies (4 papers), Nitric Oxide and Endothelin Effects (3 papers), Pregnancy and preeclampsia studies (2 papers), Biological and pharmacological studies of plants (2 papers), Fibroblast Growth Factor Research (2 papers), Lung Cancer Research Studies (2 papers) and Phytochemistry and biological activity of medicinal plants (2 papers). The work is most often cited by research in Obstetrics and Gynecology (72 citations), Pharmacology (36 citations) and Immunology and Allergy (23 citations). Han Xu has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Sandra T. Davidge, Sowndramalingam Sankaralingam, Wenlong Zhao, Michael D. Johnson, Junsong Wang, Lingyu Ruan, Chen‐Yong Lin, Feng‐Pai Chou, I‐Chu Tseng and Minghui Li. Their work appears in journals such as Journal of Ethnopharmacology, Journal of Pharmaceutical and Biomedical Analysis, American Journal of Physiology-Cell Physiology, Molecular Carcinogenesis and Journal of Proteome Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026